ATE404542T1 - 4-phenylpyrimidin-2-carbonitrilderivate - Google Patents

4-phenylpyrimidin-2-carbonitrilderivate

Info

Publication number
ATE404542T1
ATE404542T1 AT05763140T AT05763140T ATE404542T1 AT E404542 T1 ATE404542 T1 AT E404542T1 AT 05763140 T AT05763140 T AT 05763140T AT 05763140 T AT05763140 T AT 05763140T AT E404542 T1 ATE404542 T1 AT E404542T1
Authority
AT
Austria
Prior art keywords
carbonitril
phenylpyrimidine
derivatives
carbonitril derivatives
Prior art date
Application number
AT05763140T
Other languages
English (en)
Inventor
Jiaqiang Cai
Zoran Rankovic
Jennifer Helen Moir
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of ATE404542T1 publication Critical patent/ATE404542T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT05763140T 2004-06-11 2005-06-09 4-phenylpyrimidin-2-carbonitrilderivate ATE404542T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04253491 2004-06-11
EP04106949 2004-12-23

Publications (1)

Publication Number Publication Date
ATE404542T1 true ATE404542T1 (de) 2008-08-15

Family

ID=34972893

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05763140T ATE404542T1 (de) 2004-06-11 2005-06-09 4-phenylpyrimidin-2-carbonitrilderivate

Country Status (26)

Country Link
US (1) US7589095B2 (de)
EP (1) EP1758870B1 (de)
JP (1) JP2008501764A (de)
KR (1) KR20070043779A (de)
CN (1) CN1980897A (de)
AR (1) AR053303A1 (de)
AT (1) ATE404542T1 (de)
AU (1) AU2005251923A1 (de)
BR (1) BRPI0511951A (de)
CA (1) CA2567845A1 (de)
DE (1) DE602005008960D1 (de)
DK (1) DK1758870T3 (de)
EC (1) ECSP067074A (de)
ES (1) ES2313380T3 (de)
IL (1) IL179444A0 (de)
MX (1) MXPA06014423A (de)
MY (1) MY140123A (de)
NO (1) NO20070146L (de)
NZ (1) NZ551772A (de)
PE (1) PE20060432A1 (de)
PL (1) PL1758870T3 (de)
PT (1) PT1758870E (de)
RS (1) RS20060662A (de)
RU (1) RU2382773C2 (de)
TW (1) TW200614993A (de)
WO (1) WO2005121106A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090221581A1 (en) * 2005-05-25 2009-09-03 Philipp Wabnitz Methods of treating pain
US8999984B2 (en) 2006-05-26 2015-04-07 University Of Louisville Research Foundation, Inc. Macrophage migration inhibitory factor antagonists and methods of using same
WO2008129080A1 (en) 2007-04-24 2008-10-30 Ingenium Pharmaceuticals Gmbh 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
KR100936278B1 (ko) * 2007-12-14 2010-01-13 한국생명공학연구원 단백질 포스파타제의 활성을 억제하는 피리미딘 유도체또는 이의 약학적으로 허용가능한 염을 유효성분으로함유하는 암 예방 및 치료용 조성물
NZ587153A (en) * 2008-02-01 2012-10-26 Orchid Res Lab Ltd Pyrimidine-containing compounds for treating inflammation and immunological diseases
EP2480235A4 (de) 2009-09-24 2013-05-08 Univ Louisville Res Found Neue iodo-pyrimidin-derivate zur behandlung von erkrankungen und leiden im zusammenhang mit dem makrophagenmigrations-hemmenden faktor
US9155790B2 (en) 2010-05-20 2015-10-13 University of Lousiville Research Foundation, Inc. Methods and compositions for modulating ocular damage
WO2013050434A1 (en) 2011-10-06 2013-04-11 Bayer Intellectual Property Gmbh Heterocyclylpyri(mi)dinylpyrazole
CN104284895B (zh) * 2012-04-17 2016-08-31 安斯泰来制药株式会社 含氮双环式芳香族杂环化合物
CN104211645B (zh) * 2014-08-12 2016-08-24 武汉珈瑜科技有限公司 嘧啶类衍生物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO890521L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte pyrimidiner.
BR0207209A (pt) * 2001-02-14 2004-01-27 Warner Lambert Co Inibidores de metaloproteinase de matriz de pirimidina
US20030144234A1 (en) 2001-08-30 2003-07-31 Buxton Francis Paul Methods for the treatment of chronic pain and compositions therefor
GB0121033D0 (en) 2001-08-30 2001-10-24 Novartis Ag Organic compounds
AR036375A1 (es) * 2001-08-30 2004-09-01 Novartis Ag Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
SE0201976D0 (sv) 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
SE0201980D0 (sv) 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
GB0220187D0 (en) * 2002-08-30 2002-10-09 Novartis Ag Organic compounds
US7326715B2 (en) * 2005-09-23 2008-02-05 N.V. Organon 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives

Also Published As

Publication number Publication date
TW200614993A (en) 2006-05-16
ES2313380T3 (es) 2009-03-01
MXPA06014423A (es) 2007-02-19
AR053303A1 (es) 2007-05-02
BRPI0511951A (pt) 2008-01-29
RU2382773C2 (ru) 2010-02-27
CA2567845A1 (en) 2005-12-22
EP1758870A1 (de) 2007-03-07
HK1100002A1 (en) 2007-08-31
RU2007101161A (ru) 2008-07-20
PE20060432A1 (es) 2006-06-23
NZ551772A (en) 2009-05-31
KR20070043779A (ko) 2007-04-25
US7589095B2 (en) 2009-09-15
RS20060662A (sr) 2008-09-29
EP1758870B1 (de) 2008-08-13
IL179444A0 (en) 2007-05-15
AU2005251923A1 (en) 2005-12-22
PT1758870E (pt) 2008-10-15
DE602005008960D1 (de) 2008-09-25
NO20070146L (no) 2007-02-02
JP2008501764A (ja) 2008-01-24
ECSP067074A (es) 2007-01-26
US20080090813A1 (en) 2008-04-17
WO2005121106A1 (en) 2005-12-22
MY140123A (en) 2009-11-30
PL1758870T3 (pl) 2009-01-30
CN1980897A (zh) 2007-06-13
DK1758870T3 (da) 2008-10-20

Similar Documents

Publication Publication Date Title
IS8578A (is) 3- karbamoýl - 2- pýridón afleiður
DK1725553T3 (da) Tetrahydropyridoindolderivater
ATE540935T1 (de) Chinazolinderivate
DE602005011516D1 (de) Nähfadenankereinführungssystem
DE602005015457D1 (de) Ungselements
EP1769743A4 (de) Radiotomograph
DE502005005116D1 (de) Wischblatt
EP1814610A4 (de) Kathetereinfürungsgerät
DK1761541T3 (da) Pyrrazolo-pyrimidin-derivater
DE602005016654D1 (de) Ltungssystem
DK1746999T3 (da) 4-phenylamino-quinazolin-6-yl-amider
ATE553079T1 (de) Heteroarylphenylharnstoffderivat
EP1718903A4 (de) Hybridheizvorrichtung
DE602005001374D1 (de) Spurabweichwarnung
ATE417830T1 (de) Sulfonylbenzimidazolderivate
EP1754644A4 (de) Zugbetriebssteuersystem
NO20052187D0 (no) Repertierwaffe
DE602006010581D1 (de) 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
ATE485294T1 (de) Azaindol-2-carboxamid-derivate
ATE430142T1 (de) Phenylpiperazin-methanon-derivate
DE602005002296D1 (de) Buschschneider
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
DK1971588T3 (da) Tiglien-3-onderivater
EP1774546A4 (de) Zündspulanordnung
EP1793396A4 (de) Leck-transformator

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1758870

Country of ref document: EP

REN Ceased due to non-payment of the annual fee